Trials / Completed
CompletedNCT02623257
EGFR Mutations on ctDNA in Patients With Advanced NSCLC
A Diagnostic Study to Determine the Prevalence of Epidermal Growth Factor Receptor Mutations Assessed With Circulating Tumor DNA Samples in Advanced Non-small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,055 (actual)
- Sponsor
- First People's Hospital of Hangzhou · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to explore the prevalence of EGFR mutations assessed with ctDNA samples in advanced NSCLC, who had received ≤ 1 prior systemic chemotherapy regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mutation detection | |
| OTHER | ARMS | |
| GENETIC | ctDNA analysis |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-07-01
- Completion
- 2017-12-01
- First posted
- 2015-12-07
- Last updated
- 2018-02-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02623257. Inclusion in this directory is not an endorsement.